GlassScriptPhysician profile
Priscilla A Cambert
NPI 1639786668
$3,381.07
in general payments reported to CMS, 2019-2025
20 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,087 · 2022: $1,161 · 2023: $373 · 2024: $590 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.50 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,368.84 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $585.02 | 2021-2024 | Trulance, Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $537.30 | 2021-2024 | Entyvio |
| Phathom Pharmaceuticals, INC. | $208.12 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $128.35 | 2021-2025 | Tremfya |
| Nestle Healthcare Nutrition INC. | $107.34 | 2021-2023 | |
| Daiichi Sankyo INC. | $74.51 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $64.71 | 2022 | |
| Ironwood Pharmaceuticals, INC | $53.91 | 2021-2023 | Linzess |
| Intercept Pharmaceuticals, INC. | $31.71 | 2022-2023 | Ocaliva |
| Qol Medical, LLC | $31.47 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $28.53 | 2021-2022 | |
| Redhill Biopharma INC. | $28.35 | 2022 | |
| Ardelyx, INC. | $23.75 | 2022 | |
| Evoke Pharma, INC. | $22.63 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $22.34 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.97 | 2023 | Dupixent |
| Fresenius Kabi USA, LLC | $16.25 | 2023 | Idacio |
| Pfizer INC. | $16.04 | 2021 | |
| Celgene Corporation | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priscilla Cambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.